Trader consensus favoring "No" at 90.5% stems primarily from the absence of any novel pathogen demonstrating sustained human-to-human transmission capable of triggering a WHO pandemic declaration through mid-June 2026. CDC surveillance indicates COVID-19 transmission declining across most U.S. states with minimal hospitalizations, while seasonal respiratory viruses recede. Regional filovirus activity, including Bundibugyo Ebola in the DRC and Uganda, remains contained without efficient international spread, and measles increases tie to known vaccine-preventable strains rather than emerging threats. Ongoing WHO and CDC monitoring of zoonotic candidates like avian influenza and Disease X shows low near-term escalation risk per current observational data and models, though revised genomic surveillance or unexpected spillover events could alter this before year-end.